LCTX
Price
$1.48
Change
+$0.09 (+6.47%)
Updated
Mar 28, 6:59 PM EST
42 days until earnings call
VIRX
Price
$1.02
Change
-$0.06 (-5.56%)
Updated
Mar 28, 6:59 PM EST
40 days until earnings call
Ad is loading...

Compare predictions LCTX vs VIRX

Header iconLCTX vs VIRX Comparison
Open Charts LCTX vs VIRXBanner chart's image
Lineage Cell Therapeutics
Price$1.48
Change+$0.09 (+6.47%)
Volume$1.86M
CapitalizationN/A
Viracta Therapeutics
Price$1.02
Change-$0.06 (-5.56%)
Volume$33.63K
CapitalizationN/A
View a ticker or compare two or three
LCTX vs VIRX Comparison Chart

Loading...

LCTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
LCTX vs. VIRX commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Buy and VIRX is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (LCTX: $1.48 vs. VIRX: $1.04)
Brand notoriety: LCTX and VIRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 462% vs. VIRX: 64%
Market capitalization -- LCTX: $279.03M vs. VIRX: $40.84M
LCTX [@Biotechnology] is valued at $279.03M. VIRX’s [@Biotechnology] market capitalization is $40.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileVIRX’s FA Score has 1 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • VIRX’s FA Score: 1 green, 4 red.
According to our system of comparison, VIRX is a better buy in the long-term than LCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 6 TA indicator(s) are bullish while VIRX’s TA Score has 2 bullish TA indicator(s).

  • LCTX’s TA Score: 6 bullish, 4 bearish.
  • VIRX’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than VIRX.

Price Growth

LCTX (@Biotechnology) experienced а +8.82% price change this week, while VIRX (@Biotechnology) price change was -2.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

LCTX is expected to report earnings on May 09, 2024.

VIRX is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for LCTX with price predictions.
OPEN
A.I.dvisor published
a Summary for VIRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LCTX($264M) has a higher market cap than VIRX($40.8M). VIRX YTD gains are higher at: 82.439 vs. LCTX (35.780). LCTX has higher annual earnings (EBITDA): -24.04M vs. VIRX (-46.86M). VIRX has more cash in the bank: 53.7M vs. LCTX (35.5M). LCTX has less debt than VIRX: LCTX (2.95M) vs VIRX (25.6M). LCTX has higher revenues than VIRX: LCTX (8.95M) vs VIRX (0).
LCTXVIRXLCTX / VIRX
Capitalization264M40.8M647%
EBITDA-24.04M-46.86M51%
Gain YTD35.78082.43943%
P/E RatioN/A2.75-
Revenue8.95M0-
Total Cash35.5M53.7M66%
Total Debt2.95M25.6M12%
FUNDAMENTALS RATINGS
LCTX vs VIRX: Fundamental Ratings
LCTX
VIRX
OUTLOOK RATING
1..100
3836
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
86100
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
7119
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (52) in the null industry is in the same range as VIRX (71) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VIRX’s over the last 12 months.

LCTX's Profit vs Risk Rating (86) in the null industry is in the same range as VIRX (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VIRX’s over the last 12 months.

LCTX's SMR Rating (96) in the null industry is in the same range as VIRX (99) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VIRX’s over the last 12 months.

LCTX's Price Growth Rating (50) in the null industry is in the same range as VIRX (50) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VIRX’s over the last 12 months.

VIRX's P/E Growth Rating (19) in the Biotechnology industry is somewhat better than the same rating for LCTX (71) in the null industry. This means that VIRX’s stock grew somewhat faster than LCTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXVIRX
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 15 days ago
83%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
LCTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PANL6.970.13
+1.90%
Pangaea Logistics Solutions Ltd
HR14.150.21
+1.51%
Healthcare Realty Trust
NBHC36.070.10
+0.28%
NATIONAL BANK HOLDINGS Corp
MO43.62-0.04
-0.09%
Altria Group
JOB0.36-0.01
-1.56%
GEE Group

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+5.71%
MDGL - LCTX
43%
Loosely correlated
+3.18%
CMPX - LCTX
34%
Loosely correlated
-3.41%
AXON - LCTX
33%
Loosely correlated
-0.84%
BCAB - LCTX
31%
Poorly correlated
-0.58%
CDTX - LCTX
31%
Poorly correlated
+8.75%
More